Company Filing History:
Years Active: 2011
Title: Hisakazu Yamagishi: Innovator in Cancer Detection
Introduction
Hisakazu Yamagishi is a prominent inventor based in Otsu, Japan. He has made significant contributions to the field of medical technology, particularly in the detection of metastatic cancer cells. His innovative approach has the potential to improve patient outcomes in gastric cancer treatment.
Latest Patents
Hisakazu Yamagishi holds a patent for a method of detecting metastasizing cancer cells originating in stomach cancer. The patent describes a process that involves collecting a biological sample from a subject and detecting the presence of either aldehyde dehydrogenase or dopa decarboxylase in the sample. The presence of these markers indicates a high possibility of metastatic cancer cells originating from gastric cancer. This method allows for rapid and reliable detection of peritoneal metastasis in gastric cancer patients, providing crucial data for treatment decisions regarding intraperitoneal cancer chemotherapy.
Career Highlights
Yamagishi is associated with Riken Corporation, where he continues to work on innovative solutions in cancer detection. His dedication to research and development has positioned him as a key figure in the medical technology sector.
Collaborations
Hisakazu Yamagishi has collaborated with notable colleagues, including Yoshihide Hayashizaki and Yasushi Okazaki. These partnerships have fostered advancements in cancer research and detection methodologies.
Conclusion
Hisakazu Yamagishi's contributions to cancer detection exemplify the impact of innovation in medical technology. His work not only enhances diagnostic capabilities but also plays a vital role in improving treatment strategies for gastric cancer patients.